ABSTRACT
OBJECTIVE: To determine if the presence of prothrombotic polymorphisms, such as factor V G1691A (factor V Leiden) or factor II G20210A, affect the length of secondary postpartum bleeding. METHODS: We conducted a prospective and blind study that enrolled primiparous healthy women following singleton pregnancy. Whole blood was taken for determining the presence of factor V G1691A or prothrombin G20210A by PCR and specific restriction enzymes. RESULTS: We enrolled 638 women, of whom 524 had vaginal delivery, 34 had planned cesarean delivery, and 80 had emergency cesarean delivery. Seventy-nine of 524 women with vaginal delivery required vacuum, 19 women needed forceps, and 2 women required both vacuum and forceps. Seventy parturients had prothrombotic polymorphisms: 31 were heterozygote to factor V G1691A, 34 were heterozygote to prothrombin G20210A, and 1 was homozygote for the mutation. Another 4 women had both mutations. Women who gave birth by planned cesarean deliveries bled 4.9 days longer on average than women who gave birth vaginally or had emergency cesarean delivery (p = 0.03), after adjustment for length of pregnancy. The weight of the newborn and the length of the pregnancy affected the duration of bleeding. The presence of prothrombotic polymorphisms did not affect the duration of postpartum bleeding. CONCLUSIONS: The duration of secondary postpartum hemorrhage is related to length of pregnancy, neonate weight, and planned cesarean delivery but is not affected by the presence of factor V G1691A or prothrombin G20210A mutation in the primiparous women.
Subject(s)
Factor V/genetics , Postpartum Hemorrhage/etiology , Pregnancy Complications, Hematologic/etiology , Prothrombin/genetics , Adult , Birth Weight , Cesarean Section/adverse effects , Female , Gestational Age , Humans , Infant, Newborn , Polymerase Chain Reaction , Polymorphism, Genetic , Postpartum Hemorrhage/epidemiology , Postpartum Hemorrhage/genetics , Postpartum Period , Pregnancy , Pregnancy Complications, Hematologic/epidemiology , Prospective Studies , Risk Factors , Single-Blind MethodABSTRACT
OBJECTIVE: In this study we evaluated the associations between common prothrombotic factors and increased blood flow resistance in the feto-maternal circulation, intrauterine growth restriction, small for gestational age, or preeclampsia. STUDY DESIGN: A prospective study was conducted in healthy nulliparous women with spontaneous singleton pregnancy. Blood was tested for the common prothrombotic factors, i.e., factor V Leiden, factor II G20210A, methylenetetrahydrofolate reductase C677T, anticardiolipin, and lupus anticoagulant. Blood flow resistance in the uterine, placental, and umbilical arteries were assessed by multigate Doppler and compared between women with and without prothrombotic factors. The maternal, fetal, and neonatal clinical courses were also compared among these subgroups. RESULTS: Prothrombotic factors were detected in 191 of 637 (30%) subjects. No significant difference in resistance to blood flow in the feto-maternal unit was discernible between women with and without prothrombotic factors. Pregnancy-induced hypertension or preeclampsia occurred in 10 of 191 (5.2%) and in 19 of 446 (4.3%) of women with and without a prothrombotic factor respectively ( P = .59). Intrauterine growth restriction was detected at 31 weeks in 13 of 164 (7.9%) and in 42 of 377 (11.1%) fetuses of women with and without a prothrombotic factor ( P = .26), and small for gestational age at delivery was observed in 19 of 187 (10.2%) and in 41 of 413 (9.9%) of mothers with and without prothrombotic markers, respectively. CONCLUSION: The presence of prothrombotic factors in healthy nulliparous women does not compromise blood flow in the feto-maternal unit, nor is it associated with preeclampsia, intrauterine growth restriction, or small for gestational age .
